Dosage regiment of ferric maltol
The present invention relates to a dosage regimen of ST10 (ferric maltol) for use in the treatment of patients suffering from iron deficiency with or without anaemia. The invention specifically relates to use of ST10 wherein the dose is between 40 mg and 90 mg twice daily.
1. A method of treating iron deficiency in a subject with or without anaemia having inflammatory disease or acute inflammation, comprising orally administering to the subject a 40 mg to 90 mg dose or a 65 mg to 90 mg dose of ferric trimaltol, wherein 40 mg to 90 mg or 65 mg to 90 mg refers to the amount of elemental iron in the dose; and wherein the 40 mg to 90 mg dose is administered twice daily to achieve a total daily dose of 80 mg to 180 mg elemental iron, or wherein the 65-90 mg dose is administered once daily; and wherein the inflammatory disease or acute inflammation is selected from chronic kidney disease (CKD), Systemic Lupus (SLE), rheumatoid arthritis, a haematological cancer, a chronic bacterial infection, viral hepatitis, HIV, AIDS and a disease of the gastrointestinal tract.
2. The method according to claim 1 wherein the dose is between 60 mg to 90 mg, wherein the dose is administered twice daily to achieve a total daily dose of 120 mg to 180 mg elemental iron.
3. The method according to claim 1 wherein the dose is between 65 mg to 90 mg, wherein the dose is administered once daily.
4. The method according to claim 1 wherein the dose is 90 mg, wherein the dose is administered twice daily to achieve a total daily dose of 180 mg elemental iron.
5. The method according to claim 1 wherein the dose is 60 mg, wherein the dose is administered twice daily to achieve a total daily dose of 120 mg elemental iron.
6. The method according to claim 1 wherein the dose is administered on two separate occasions during the waking hours.
7. The method according to claim 6 wherein the dose is administered on an empty stomach.
8. The method according to claim 3 wherein the 90 mg dose is administered orally once daily.
9. The method according to claim 1 wherein the dose is administered for up to a 16 week period.
10. The method according to claim 1 wherein the dose is administered indefinitely as a maintenance dose.
11. The method according to claim 10 wherein the dose is administered orally every two, three, four, five, six or seven days.
12. The method according to claim 1 wherein iron deficiency is iron deficiency with anaemia.
13. The method according to claim 1 wherein the iron deficiency is caused by a disease of the gastrointestinal tract selected from Crohn's disease and ulcerative colitis.
14. The method of claim 1 , wherein iron deficiency is caused by Hodgkin's disease, osteomyelitis or inflammatory bowel disease.
15. A method of treating iron deficiency in a subject with or without anaemia having inflammatory disease or acute chronic inflammation, comprising orally administering to the subject a 40 mg to 90 mg dose or a 65 mg to 90 mg dose of ferric trimaltol, wherein 40 mg to 90 mg or 65 mg to 90 mg refers to the amount of elemental iron in the dose; and wherein the 40 mg to 90 mg dose is administered twice daily to achieve a total daily dose of 80 mg to 180 mg elemental iron, or wherein the 65-90 mg dose is administered once daily.
16. The method according to claim 15 wherein the dose is between 60 mg to 90 mg, wherein the dose is administered twice daily to achieve a total daily dose of 120 mg to 180 mg elemental iron.
17. The method according to claim 15 wherein the dose is between 65 mg to 90 mg, wherein the dose is administered once daily.
18. The method according to claim 15 wherein the dose is 90 mg, wherein the dose is administered twice daily to achieve a total daily dose of 180 mg elemental iron.
19. The method according to claim 15 wherein the dose is 60 mg, wherein the dose is administered twice daily to achieve a total daily dose of 120 mg elemental iron.
20. The method according to claim 15 wherein the dose is administered on two separate occasions during the waking hours.
21. The method according to claim 20 wherein the dose is administered on an empty stomach.
22. The method according to claim 17 wherein the 90 mg dose is administered orally once daily.
23. The method according to claim 15 wherein the dose is administered for up to a 16 week period.
24. The method according to claim 15 wherein the dose is administered indefinitely as a maintenance dose.
25. The method according to claim 24 wherein the dose is administered orally every two, three, four, five, six or seven days.